ZYLOXTB(02190) spent HK$1.1393 million to repurchase 48,000 shares on April 20th.
Guichuang Tongqiao (02190) announced that on April 20, 2026, the company spent 1.1393 million Hong Kong dollars to repurchase 48,000 shares.
ZYLOXTB (02190) announced that on April 20, 2026, the company spent 1.1393 million Hong Kong dollars to repurchase 48,000 shares.
Related Articles
.png)
Jiangsu Hengrui Pharmaceuticals (01276): HRS9531 Injection Received Approval Notice for Clinical Trials of Drugs
PW MEDTECH (01358) spent 448,000 Hong Kong dollars to repurchase 380,000 shares on April 20th.
Jiangsu Hengrui Pharmaceuticals(01276): SHR-A1811 included in revolutionary therapeutic drug list
Jiangsu Hengrui Pharmaceuticals (01276): HRS9531 Injection Received Approval Notice for Clinical Trials of Drugs
PW MEDTECH (01358) spent 448,000 Hong Kong dollars to repurchase 380,000 shares on April 20th.
Jiangsu Hengrui Pharmaceuticals(01276): SHR-A1811 included in revolutionary therapeutic drug list
RECOMMEND
Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026
Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026
Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026
